Assess if the pain is related to dehydration or low blood sugar, which are common when starting weight loss medications
Safety Profile (Phase 2) The most common adverse events were gastrointestinal and consistent with the incretin drug class: - Nausea - Diarrhea - Vomiting - Constipation - Decreased appetite These GI events were dose-related, mostly mild to moderate, and partially mitigated by starting at a lower initial dose (2 mg vs
Together they make Wegovy the first weight-loss medication with an FDA-approved CV-reduction indication
For example, one case study reported worsened lactose intolerance and new gluten intolerance following semaglutide treatment for weight loss
6, 8, 9 * Other brands of liraglutide, e.g
Were about to open up our manufacturing plant this week, where we will be releasing sterile injectables for generics that are on short supply. Cuban said the company plans to meet the demand of shortages through its robotically-driven production line, which it plans to expand so that over the next five years, there will no longer be any more shortages in sterile injectables. Cuban did note, however, that the company was not making money yet
